EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 1 of 3 (Hits 1 to 20 of 43)
ID
Country
PT provider
PT scheme
Last changed
947164 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation [EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação] Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation [EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação] 2022-07-26
PT name (Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation)
Scheme name in national language (EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação)
Tested property (Coronavirus (SARS-CoV2): antigen research by automation)

935461 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology SARS-CoV-2 Point of Care [SARS-CoV-2 Point of Care] SARS-CoV-2 Point of Care [SARS-CoV-2 Point of Care] 2023-07-14
PT name (SARS-CoV-2 Point of Care)
Scheme name in national language (SARS-CoV-2 Point of Care)
Tested property (To determine the presence / absence of SARS-CoV-2 antigen/ nucleic acid by point of care devices such as lateral flow, LAMP and antigen test)

935187 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2) [EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2)] Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2) [EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2)] 2022-05-12
PT name (Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2))
Scheme name in national language (EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2))
Tested property (RDT - Neutralizing Antibody Research: Coronavirus (SARS-CoV2))

925094 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] 2022-05-13
PT name (Molecular detection of SARS-CoV-2)
Scheme name in national language (Molecular detection of SARS-CoV-2)
Test item (/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed))
Tested property (SARS-CoV-2 nucleic acid)

910247 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2) [EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2) ] Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2) [EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2) ] 2021-12-06
PT name (Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2))
Scheme name in national language (EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2))
Tested property (Coronavírus (SARS-CoV2))

907768 Germany Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] 2021-11-25
PT name (Antibodies against SARS-CoV-2)
Scheme name in national language (Antikörper gegen SARS-CoV-2)
Tested property (Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG)

883284 Thailand Department of Medical Sciences PT provider (DMSc PT provider) Department of Medical Sciences PT provider (DMSc PT provider) SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] 2024-01-09
PT name (SARS-CoV-2 detection by Real-time RT-PCR)
Scheme name in national language (SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข))

880833 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular panel of Respiratory Infections and Pneumonia [EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias] Clinical PT - Molecular panel of Respiratory Infections and Pneumonia [EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias] 2023-05-29
Tested property (Coronavírus (SARS-CoV-2))

837442 Brazil PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA [COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA] COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA [COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA] 2022-05-30
PT name (COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA)
Scheme name in national language (COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA)

824901 Germany Reference Institute for Bioanalytics Reference Institute for Bioanalytics SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] 2021-02-16
PT name (SARS-CoV-2 Immunology)
Scheme name in national language (SARS-CoV-2 Immunologie)
Tested property (Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA)

820055 United Kingdom INSPEC International Limited INSPEC International Limited Personal Protective Equipment [Personal Protective Equipment] Personal Protective Equipment [Personal Protective Equipment] 2021-01-18
Related legislation or standard (European PPE Regulation (EU 2016/425) National legislation regarding PPE for Covid-19)

807218 Brazil QLM Inovações Tecnológicas QLM Inovações Tecnológicas Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] 2020-11-23
Tested property (SAR)

794057 Australia RCPAQAP RCPAQAP PHLN: SARS-CoV-2 and other coronaviruses PHLN: SARS-CoV-2 and other coronaviruses 2020-10-23
PT name (PHLN: SARS-CoV-2 and other coronaviruses)
Remarks (Department of Health funded COVID-19 program. Three rounds of this module were offered in 2020 in) (response to the COVID-19 pandemic with plans for another in 2021. This module is suitable for all) (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2. Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.)
Tested property (Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated))

790376 Australia RCPAQAP RCPAQAP PoCT: COVID-19 serology (IgG/IgM) PoCT: COVID-19 serology (IgG/IgM) 2020-10-26
PT name (PoCT: COVID-19 serology (IgG/IgM))
Tested property (COVID-19 Serology)

790103 Australia RCPAQAP RCPAQAP Coronavirus SARS CoV-2 Antibodies Coronavirus SARS CoV-2 Antibodies 2020-10-27
PT name (Coronavirus SARS CoV-2 Antibodies)
Tested property (SARS CoV-2)

789879 Australia RCPAQAP RCPAQAP Molecular Respiratory Pathogens Molecular Respiratory Pathogens 2020-10-28
Tested property (Coronavirus (OC43, NL63, SARS-CoV-2))

789737 Australia RCPAQAP RCPAQAP Molecular Coronavirus SARS-CoV-2 Molecular Coronavirus SARS-CoV-2 2020-10-28
PT name (Molecular Coronavirus SARS-CoV-2)
Tested property (Coronavirus SARS-CoV2)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2022-05-04
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome)
Testing method (The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.)

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] 2024-03-13
PT name (SARS-CoV-2, molecular detection)
Scheme name in national language (SARS-CoV-2, molecular detection)
Tested property (SARS-CoV-2 virus)

705758 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - TLR Immunology Coronavírus (SARS-CoV2) [EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)] Clinical PT - TLR Immunology Coronavírus (SARS-CoV2) [EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)] 2023-01-31
PT name (Clinical PT - TLR Immunology Coronavírus (SARS-CoV2))
Scheme name in national language (EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2))

Page 1 of 3 (Hits 1 to 20 of 43)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5